Clinical Trial Update: Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Bromday (bromfenac ophthalmic solution) 0.09% once daily with Nevanac (nepafenac ophthalmic suspension) 0.1% for inflammation in pseudop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Pseudophakia

Drugs mentioned

• Bromday (bromfenac)
• Nevanac (nepafenac)

Snippet

Sponsor: Toyos Clinic | Conditions: Inflammation, Pseudophakia | Phase 4 | Status: COMPLETED | Results posted: 2013-09-26